Fmoc-L-酪氨酸
Fmoc-L-酪氨酸结构式
|
常用名 | Fmoc-L-酪氨酸 | 英文名 | Fmoc-Tyr-OH |
|---|---|---|---|---|
| CAS号 | 92954-90-0 | 分子量 | 403.42700 | |
| 密度 | 1.336g/cm3 | 沸点 | 672.6ºC at 760 mmHg | |
| 分子式 | C24H21NO5 | 熔点 | 180 - 185ºC (Decomposes) | |
| MSDS | 中文版 美版 | 闪点 | 360.6ºC |
|
Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumors.
Cancer Sci. 106 , 747-56, (2015) L-type amino acid transporter 1 (LAT1), overexpressed on the membrane of various tumor cells, is a potential target for tumor-targeting therapy. This study aimed to develop a LAT1-mediated chemotherapeutic agent. We screened doxorubicin modified by seven diff... |
|
|
Design and synthesis of newN-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents
Eur. J. Med. Chem. 44 , 1933-40, (2009) Twenty-four new dipeptide analogs ( 1– 24) of aurantiamide acetate were designed, synthesized, and assayed for effects on superoxide anion generation and elastase release by human neutrophils in response to fMLP/CB. Among them, seven N-(fluorenyl-9-methoxycar... |
期刊文献综述：
更多...